HYCODAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hycodan, and when can generic versions of Hycodan launch?
Hycodan is a drug marketed by Genus and is included in one NDA.
The generic ingredient in HYCODAN is homatropine methylbromide; hydrocodone bitartrate. There are five drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the homatropine methylbromide; hydrocodone bitartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Hycodan
A generic version of HYCODAN was approved as homatropine methylbromide; hydrocodone bitartrate by AVANTHI INC on August 7th, 2017.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HYCODAN?
- What are the global sales for HYCODAN?
- What is Average Wholesale Price for HYCODAN?
Summary for HYCODAN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Drug Prices: | Drug price information for HYCODAN |
What excipients (inactive ingredients) are in HYCODAN? | HYCODAN excipients list |
DailyMed Link: | HYCODAN at DailyMed |
Pharmacology for HYCODAN
Drug Class | Opioid Agonist |
Mechanism of Action | Opioid Agonists |
US Patents and Regulatory Information for HYCODAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Genus | HYCODAN | homatropine methylbromide; hydrocodone bitartrate | SYRUP;ORAL | 005213-002 | Jul 26, 1988 | AA | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Genus | HYCODAN | homatropine methylbromide; hydrocodone bitartrate | TABLET;ORAL | 005213-001 | Jul 26, 1988 | AA | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |